Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: Questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials

Lung Cancer

Volumn 34, Issue 1, 2001, Pages 29-36

  Ichinose, Yukito ^a   Kato, Harubumi ^b   Koike, Teruaki ^c   Tsuchiya, Ryosuke ^d   Fujisawa, Takehiko ^e   Shimizu, Nobuyoshi ^f   Watanabe, Yoh ^g   Mitsudomi, Tetsuya ^h   Yoshimura, Masahiro ⁱ  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c NIIGATA CANCER CENTER HOSPITAL   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e CHIBA UNIVERSITY   (Japan)

^f OKAYAMA UNIVERSITY   (Japan)

^g KANAZAWA UNIVERSITY   (Japan)

^h AICHI CANCER CENTER HOSPITAL   (Japan)

ⁱ HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

Author keywords

Local recurrence; Non small cell lung cancer; Number of N2 stations; Pathological stage IIIA N2 disease; Survival

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; JAPAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RECURRENT DISEASE; SURVIVAL RATE;

EID: 0034857648     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00207-0     Document Type: Article

References (15)

1. The role of surgery in N2 lung cancer
2. Aggressive surgical intervention in N2 non-small cell lung cancer of the lung
3. Surgical management of non-small cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease)
4. Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases
5. Clinical prognostic factors in surgically treated stage IIIA-N2 non-small cell lung cancer: Analysis of the literature
6. The prognosis of surgically resected N2 non-small cell lung cancer: The importance of clinical N status
7. Survival of patients with resected N2 non-small-cell lung cancer: Evidence for a subclassification and implications
8. Chemotherapy in non-small cell lung cancer: A meta-analysis using update data on individual patients from 52 randomised clinical trials
9. Postoperative radiotherapy in non-small-cell lung cancer: Systemic review and meta-analysis of individual patient data from nine randomised controlled trials
10. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer
11. Effectiveness of radical systemic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer
12. Lymph node mapping and curability at various levels of metastasis in resected lung cancer
13. Mediastinal lymph node dissection in resected lung cancer: Morbidity and accuracy of staging
14. The impact of surgical adjuvant thoracic radiation therapy for patients with non-small cell lung carcinoma with ipsilateral mediastinal lymph node involvement